Fulgent Genetics Pre-Tax Profit Margin 2015-2024 | FLGT
Fulgent Genetics pre-tax profit margin from 2015 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Fulgent Genetics Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-09-30 | $0.28B | $-0.19B | -67.99% |
| 2024-06-30 | $0.29B | $-0.16B | -56.01% |
| 2024-03-31 | $0.29B | $-0.17B | -57.99% |
| 2023-12-31 | $0.29B | $-0.17B | -60.00% |
| 2023-09-30 | $0.29B | $-0.06B | -21.60% |
| 2023-06-30 | $0.31B | $-0.07B | -21.75% |
| 2023-03-31 | $0.37B | $-0.04B | -10.41% |
| 2022-12-31 | $0.62B | $0.19B | 29.89% |
| 2022-09-30 | $0.80B | $0.37B | 45.95% |
| 2022-06-30 | $0.93B | $0.53B | 56.97% |
| 2022-03-31 | $0.95B | $0.61B | 64.26% |
| 2021-12-31 | $0.99B | $0.68B | 68.28% |
| 2021-09-30 | $1.04B | $0.75B | 72.68% |
| 2021-06-30 | $0.91B | $0.66B | 72.20% |
| 2021-03-31 | $0.77B | $0.56B | 72.45% |
| 2020-12-31 | $0.42B | $0.29B | 68.96% |
| 2020-09-30 | $0.14B | $0.07B | 48.15% |
| 2020-06-30 | $0.04B | $0.00B | 6.98% |
| 2020-03-31 | $0.03B | 0 | 0.00% |
| 2019-12-31 | $0.03B | 0 | 0.00% |
| 2019-09-30 | $0.03B | $-0.00B | -3.45% |
| 2019-06-30 | $0.03B | $-0.00B | -16.00% |
| 2019-03-31 | $0.02B | $-0.01B | -22.73% |
| 2018-12-31 | $0.02B | $-0.01B | -22.73% |
| 2018-09-30 | $0.02B | $-0.01B | -30.00% |
| 2018-06-30 | $0.02B | $-0.01B | -31.58% |
| 2018-03-31 | $0.02B | $-0.01B | -26.32% |
| 2017-12-31 | $0.02B | $-0.00B | -15.79% |
| 2017-09-30 | $0.02B | 0 | 0.00% |
| 2017-06-30 | $0.02B | 0 | 0.00% |
| 2017-03-31 | $0.02B | $-0.00B | -20.00% |
| 2016-12-31 | $0.02B | $-0.01B | -27.78% |
| 2016-06-30 | $0.01B | $-0.00B | -40.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.563B | $0.289B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems (INSP) | United States | $5.669B | 176.81 |
| Hims & Hers Health (HIMS) | United States | $5.506B | 140.00 |
| Tempus AI (TEM) | United States | $5.393B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.799B | 0.00 |
| Enovis (ENOV) | United States | $2.475B | 16.78 |
| Privia Health (PRVA) | United States | $2.357B | 196.40 |
| Azenta (AZTA) | United States | $2.286B | 122.05 |
| Omnicell (OMCL) | United States | $2.053B | 67.15 |
| 10x Genomics (TXG) | United States | $1.718B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.568B | 0.00 |
| Schrodinger (SDGR) | United States | $1.486B | 0.00 |
| Phreesia (PHR) | United States | $1.464B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.846B | 0.00 |
| Standard BioTools (LAB) | United States | $0.651B | 0.00 |
| Talkspace (TALK) | United States | $0.529B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.476B | 82.40 |
| Health Catalyst (HCAT) | United States | $0.446B | 0.00 |
| TruBridge (TBRG) | United States | $0.297B | 86.52 |
| Pulmonx (LUNG) | United States | $0.257B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.114B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.090B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| CareCloud (CCLD) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.061B | 0.00 |
| 111 (YI) | China | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Precipio (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |